Trials / Terminated
TerminatedNCT03788369
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization, a Non-randomized, Prospective, Open-label Registry in Real-world Practice
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.
Conditions
- Percutaneous Coronary Revascularization
- Coronary Stenosis
- Coronary Artery Disease Progression
- Coronary Artery Bypass Grafting
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hybrid Coronary Revascularization | Hybrid coronary revascularization (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of non-left anterior descending vessels. |
Timeline
- Start date
- 2019-04-05
- Primary completion
- 2026-04-13
- Completion
- 2026-04-13
- First posted
- 2018-12-27
- Last updated
- 2026-04-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03788369. Inclusion in this directory is not an endorsement.